Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.
Public ClinicalTrials.gov record NCT04250337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled, parallel-group study which is 16 weeks in duration. The study is designed to evaluate the safety and efficacy of lebrikizumab when used in combination with topical corticosteroid (TCS) treatment compared with placebo in combination with TCS treatment for moderate-to-severe atopic dermatitis.
Study identification
- NCT ID
- NCT04250337
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 228 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2, 2020
- Primary completion
- Aug 10, 2021
- Completion
- Sep 15, 2021
- Last update posted
- May 8, 2022
2020 – 2021
United States locations
- U.S. sites
- 43
- U.S. states
- 18
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigate MD | Scottsdale | Arizona | 85255 | — |
| Orange County Research Institute | Anaheim | California | 92801 | — |
| Bakersfield Dermatology and Skin Cancer Medical Group | Bakersfield | California | 93309 | — |
| Wallace Medical Group, Inc. | Beverly Hills | California | 90211 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| California Allergy and Asthma Medical Group + Research Center | Los Angeles | California | 90025 | — |
| Keck School of Medicine University of Southern California | Los Angeles | California | 90033 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| LA Universal Research Center, INC | Los Angeles | California | 90057 | — |
| ACRC Studies | San Diego | California | 92119 | — |
| University Clinical Trials, Inc. | San Diego | California | 92123 | — |
| Southern California Dermatology, Inc. | Santa Ana | California | 92701 | — |
| Foxhall Dermatology | Washington D.C. | District of Columbia | 20016 | — |
| St. Francis Medical Institute | Clearwater | Florida | 33765 | — |
| University of Florida - Gainesville | Gainesville | Florida | 32606 | — |
| Direct Helpers Medical Center | Hialeah | Florida | 33012 | — |
| The Community Research of South Florida | Hialeah | Florida | 33016 | — |
| GSI Clinical Research, LLC | Margate | Florida | 33063 | — |
| Vitae Research Center, LLC | Miami | Florida | 33135 | — |
| Well Pharma Medical Research Corp. | Miami | Florida | 33143 | — |
| ForCare Clinical Research | Tampa | Florida | 33613-1244 | — |
| Advanced Medical Research | Sandy Springs | Georgia | 30328 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Dermatology and Skin Cancer Specialists | Rockville | Maryland | 20850 | — |
| ActivMed Practices and Research | Beverly | Massachusetts | 01915 | — |
| Beacon Clinical Research LLC | Quincy | Massachusetts | 02169 | — |
| Fivenson Dermatology | Ann Arbor | Michigan | 48103 | — |
| Clarkston Skin Research | Clarkston | Michigan | 48346 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| ALLCUTIS Research | Portsmouth | New Hampshire | 03801 | — |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | — |
| Sadick Research Group | New York | New York | 10075 | — |
| OnSite Clinical Solutions | Charlotte | North Carolina | 28277 | — |
| Wilmington Dermatology Center | Wilmington | North Carolina | 28405 | — |
| Clinical Research Institute | Medford | Oregon | 97504 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| OHSU Center for Health and Healing | Portland | Oregon | 97239 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Clinical Research Center of the Carolinas | Charleston | South Carolina | 29407 | — |
| Arlington Research Center, Inc | Arlington | Texas | 76011 | — |
| Dermatology Treatment and Research Center | Dallas | Texas | 75230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04250337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04250337 live on ClinicalTrials.gov.